Jane Street
BFRI icon

Jane Street’s Biofrontera BFRI Stock Holding History

Jane Street’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,820
Closed -$18.7K – 11585
2025
Q4 		$18.7K Buy
+32,820
New +$29.7K ﹤0.01% 10744
2023
Q1 		– Sell
-552
Closed -$10.1K – 9030
2022
Q4 		$10.1K Sell
552
-201
-27% -$4.11K ﹤0.01% 8762
2022
Q3 		$16K Buy
753
+243
+48% +$6.64K ﹤0.01% 9248
2022
Q2 		$19K Buy
+510
New +$30.9K ﹤0.01% 9172

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's BFRI Position: Q1 2026 in Review

Jane Street sold out of Biofrontera (BFRI) in Q1 2026, closing a stake of 32,820 shares — an estimated $18.7K sold.

Jane Street first reported a position in BFRI in Q2 2022 and held it in 4 quarters. The position peaked at $19K in Q2 2022. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • Jane Street reported no remaining Biofrontera position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 32,820 Biofrontera shares in Q1 2026, an estimated $18.7K.
  • Jane Street first reported a position in Biofrontera in Q2 2022 and held it in 4 quarters.
  • Jane Street's Biofrontera position peaked at $19K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.